Amy (Carver) Mulesky
About Amy (Carver) Mulesky
Amy (Carver) Mulesky is the Associate Director of Pharmaceutical Program Management at Bristol-Myers Squibb, with over 30 years of experience in the pharmaceutical industry.
Title
Amy (Carver) Mulesky currently holds the position of Associate Director, Pharmaceutical Program Management at Bristol-Myers Squibb. Her role is focused on overseeing pharmaceutical program initiatives within the company.
Current Company
Amy (Carver) Mulesky is employed at Bristol-Myers Squibb. She has been with the company since 1988, demonstrating a long-term commitment and consistent career progression within the pharmaceutical industry.
Career History at Bristol-Myers Squibb
Amy (Carver) Mulesky's career at Bristol-Myers Squibb spans over three decades. She began as a Staff/Senior Process Engineer from 1988 to 1997 before transitioning to various roles including Project Manager (1997-2010 and 2011-2013), Manager of Manufacturing Technology (2010-2011), and her current role as Associate Director, Pharmaceutical Program Management. This progression illustrates her adaptability and diverse skill set in pharmaceutical program management and manufacturing technology.
Education and Expertise
Amy (Carver) Mulesky earned a degree in Chemical Engineering, Honors from Purdue University. Her honors bachelor thesis focused on 'Statistical Model Discrimination and Precise Parameter Estimation.' She is also certified as a Project Management Professional (PMP) by the Project Management Institute, which underpins her extensive experience in project management within the pharmaceutical sector.
Professional Experience
Throughout her career at Bristol-Myers Squibb, Amy (Carver) Mulesky has accumulated over 30 years of experience in the pharmaceutical industry. Her expertise encompasses manufacturing technology and project management. Her role evolution from a technical staff engineer to various managerial positions, including her current role as Associate Director, underscores her broad knowledge and leadership capabilities in the industry.